Clinical Trial Update: Toripalimab Combined With FLOT Neoadjuvant Chemotherapy in Patients With Resectable Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating toripalimab in combination with FLOT neoadjuvant chemotherapy for resectable gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Toripalimab (Toripalimab)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN